Page last updated: 2024-08-26

fluoromisonidazole and Carcinoma 256, Walker

fluoromisonidazole has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barthel, H; Dannenberg, C; Kluge, R; Kumar, P; Patt, M; Sabri, O; Seese, A; Sorger, D; Tannapfel, A; Wiebe, LI	1

Other Studies

1 other study(ies) available for fluoromisonidazole and Carcinoma 256, Walker

Article	Year
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nuclear medicine and biology, 2003, Volume: 30, Issue:3 Topics: Animals; Carcinoma 256, Walker; Female; Misonidazole; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured	2003

Article

Year

[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.

Nuclear medicine and biology, 2003, Volume: 30, Issue:3

Topics: Animals; Carcinoma 256, Walker; Female; Misonidazole; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured

2003